Michael Bourque's Insider Trades & SAST Disclosures
Michael Bourque's most recent trade in Inogen Inc was a trade of 51,020 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 28, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Michael Bourque.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Inogen Inc | Michael Bourque | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 51,020 | 51,020 | - | - | Restricted Stock Unit | |
| Inogen Inc | Michael Bourque | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 47,625 | 63,387 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Michael Bourque | EVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 25,000 | 50,000 | - | - | Restricted Stock Unit | |
| Inogen Inc | Michael Bourque | EVP, CFO & Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 25,000 | 25,600 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Michael Bourque | EVP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 28 Feb 2025 | 18,741 | 44,646 (0%) | 0% | 8.3 | 156,113 | Common Stock |
| Inogen Inc | Michael Bourque | EVP, CFO & Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.33 per share. | 28 Feb 2025 | 9,838 | 15,762 (0%) | 0% | 8.3 | 81,951 | Common Stock |
| Inogen Inc | Michael Bourque | EVP, CFO & Treasurer | Purchase of securities on an exchange or from another person at price $ 8.32 per share. | 28 Feb 2025 | 3,000 | 47,646 (0%) | 0% | 8.3 | 24,960 | Common Stock |
| Inogen Inc | Michael Bourque | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 8.33 per share. | 28 Feb 2025 | 600 | 600 (0%) | 0% | 8.3 | 4,998 | Common Stock |
| Inogen Inc | Michael Bourque | EVP, CFO & Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 75,000 | 75,000 | - | - | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges